Overview
Vaccine technology encompasses the scientific principles, platforms, and methods used to design, produce, and deliver vaccines that prevent or mitigate infectious and, increasingly, non-infectious disease. Vaccines work by presenting antigens to the immune system so that protective, often long-lasting, immunity develops without causing the disease itself, preparing the body to respond rapidly to subsequent exposure. The technologies that achieve this span several major approaches: live attenuated and inactivated whole-pathogen vaccines; subunit, recombinant, and conjugate vaccines that use defined antigens; and newer platforms including viral-vector and nucleic-acid vaccines that instruct host cells to produce target antigens. Each platform balances considerations of immunogenicity, safety, stability, manufacturing scalability, and speed of development, and many are enhanced by adjuvants or delivery systems that strengthen and shape the immune response. As a branch of biotechnology and a cornerstone of immunisation, vaccine technology underpins the control of preventable disease and the capacity to respond to emerging threats, including the rapid development of vaccines during outbreaks. Beyond preventing infection, evolving vaccine technologies are being explored for therapeutic applications such as cancer. By translating immunological knowledge into deployable products, vaccine technology enables the prevention of disease and remains central to efforts to reduce illness and death from infectious causes.
Research published in this journal
7 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Predictors of COVID-19 Vaccine Hesitancy in North-Central Nigeria
Predictors of COVID-19 Vaccine Uptake Among Healthcare Workers in Kiambu County, Kenya
Vaccine Hesitancy: A significant Challange
A High Volume, User-Friendly Immunization Clinic in Vellore, India: A Model for Urban Hospitals
Epidemiology and Management of Seasonal Influenza Outbreaks in Long-Term Care Facilities in the Health Service Executive East Area of Ireland During the 2013-2014 Influenza Season.
Retraction: Efficacy of BCG Vaccine and Role of Non Specific Sensitivity Due to Atypical Mycobacteria
How this research is being cited
The 7 articles above have been cited 25 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
RajeevZachariah Kompithra et al. · 2025 · Indian Journal of Medical Microbiology
-
V. Ramasubramanian et al. · 2025 · Journal of Association of Physicians of India
-
2025 · Journal of the Association of Physicians of India
-
Therdpong Thongseiratch et al. · 2024 · Vaccines
-
2024 · Vaccines
-
Myrte Wassenaar et al. · 2024 · BMC Public Health
-
2023 · Vaccine X
-
2023 · Healthline
A sample of recent works citing this journal's research on Vaccine Technology, linking to each citing work.